CathVision Unveils Cutting-Edge Electrophysiology Solutions at HRS 2025 in San Diego
CathVision to Showcase Innovations in Electrophysiology at HRS 2025
CathVision, recognized as a pioneer in the field of cardiac electrophysiology, is gearing up for one of the most significant events in the medical calendar—the Heart Rhythm Society (HRS) 2025 Annual Scientific Sessions. The event is slated to take place from April 24th to 27th at the San Diego Convention Center, where a confluence of global electrophysiology experts, healthcare professionals, and industry leaders will gather to discuss the advancing frontiers in cardiac care.
Focus on Groundbreaking Presentations
At this year's HRS, CathVision promises to unveil substantial advancements in electrophysiological solutions, with two major studies scheduled for presentation:
1. Measurement of Unipolar Residual Signals Following Pulsed-Field Ablation (PFA) by Dr. Keita Watanabe from Mt. Sinai Hospital in New York. This session will take place on April 24th from 5:00 PM to 6:30 PM PDT.
2. Detection of Electrically Silent Gaps Using a Unipolar Local Energy Algorithm in Pulsed-Field and RF Ablation by Dr. Tom De Potter from OLV Aalst in Belgium, set for April 25th from 3:30 PM to 5:30 PM PDT.
These groundbreaking studies will reflect the cutting-edge methodologies and innovative applications that are redefining the landscape of cardiac intervention.
Engaging the Community
To maximize visitor engagement, CathVision will host demonstrations at its booth (#1341), encouraging attendees to dive deep into discussions surrounding their latest technologies. The CathVision team will include senior executives, clinical experts, and researchers who will outline the procedural efficiencies and clinical applications that their innovative products offer. Discussions will revolve around how their advancements can help improve patient outcomes by enhancing the precision and effectiveness of ablation procedures.
Mads Matthiesen, CEO of CathVision, expressed his enthusiasm: “We are thrilled to showcase our scientific advancements at HRS 2025, which underpin our dedication to transforming cardiac electrophysiology. Our state-of-the-art algorithms and measurement procedures empower clinicians to achieve optimal ablation results, ultimately benefiting patients globally.”
About CathVision
Founded in 2013 and headquartered in Denmark, CathVision focuses on revolutionizing cardiac electrophysiology with innovative technological solutions that provide unparalleled signal clarity and actionable insights during catheter ablation procedures. One of their flagship products, the ECGenius System, incorporates artificial intelligence and advanced algorithms into its CARDIALYTICS suite of modules. This integration allows clinicians to make better-informed clinical decisions that enhance the chances of successful patient outcomes.
For more insights and detailed discussions, healthcare professionals and interested parties are encouraged to visit CathVision's booth during the event, or to explore more about their innovative solutions through their website at www.cathvision.com. Additionally, for real-time updates, follow CathVision on their LinkedIn and Twitter accounts.
As the landscape of cardiac care continues to evolve, events like HRS 2025 play a pivotal role in shaping future practices. CathVision's participation is poised to contribute to meaningful advancements in patient care and outcomes in the field of electrophysiology.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.